Drugs / Vitamin K2 (MK-7)
last change Jun 2025 re-read 2 minutes ago

Vitamin K2 (MK-7)

Developed for
osteoarthritis, knee
Investigated by
Boston University · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT06385275 Jun 2025 → Dec 2026 expected osteoarthritis, knee Boston University Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Vitamin K2 (MK-7) ClinicalTrials.gov intervention name — accepted as the source's own label NCT06385275